Medicine
Active substance
Licence holder
Status
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Not marketed
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Marketed
Amlodipine, Valsartan
Not marketed
Amlodipine, Valsartan, Hydrochlorothiazide
Marketed
Amlodipine, Valsartan, Hydrochlorothiazide
Marketed
Amlodipine, Valsartan, Hydrochlorothiazide
Marketed
Perindopril arginine, Indapamide, Amlodipine
—
Perindopril arginine, Indapamide, Amlodipine
—
Perindopril arginine, Indapamide, Amlodipine
—
Perindopril arginine, Indapamide, Amlodipine
—
Perindopril arginine, Indapamide, Amlodipine
—
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide
Marketed